TCTC Holdings’s Core Laboratories CLB Stock Holding History

TCTC Holdings’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-600	Closed	-$9.62K	–	281
2025 Q4	$9.62K	Hold	600	–	–	﹤0.01%	498
2025 Q3	$7.42K	Hold	600	–	–	﹤0.01%	508
2025 Q2	$6.91K	Hold	600	–	–	﹤0.01%	548
2025 Q1	$8.99K	Hold	600	–	–	﹤0.01%	552
2024 Q4	$10.4K	Hold	600	–	–	﹤0.01%	521
2024 Q3	$11.1K	Hold	600	–	–	﹤0.01%	426
2024 Q2	$12.2K	Hold	600	–	–	﹤0.01%	431
2024 Q1	$10.2K	Hold	600	–	–	﹤0.01%	431
2023 Q4	$10.6K	Hold	600	–	–	﹤0.01%	412
2023 Q3	$14.4K	Hold	600	–	–	﹤0.01%	347
2023 Q2	$13.9K	Hold	600	–	–	﹤0.01%	344
2023 Q1	$13.2K	Hold	600	–	–	﹤0.01%	373
2022 Q4	$12.2K	Hold	600	–	–	﹤0.01%	352
2022 Q3	$8K	Hold	600	–	–	﹤0.01%	361
2022 Q2	$12K	Hold	600	–	–	﹤0.01%	346
2022 Q1	$19K	Hold	600	–	–	﹤0.01%	334
2021 Q4	$13K	Hold	600	–	–	﹤0.01%	383
2021 Q3	$17K	Hold	600	–	–	﹤0.01%	383
2021 Q2	$23K	Hold	600	–	–	﹤0.01%	322
2021 Q1	$17K	Hold	600	–	–	﹤0.01%	339
2020 Q4	$16K	Hold	600	–	–	﹤0.01%	328
2020 Q3	$9K	Hold	600	–	–	﹤0.01%	338
2020 Q2	$12K	Buy	+600	New	+$10.8K	﹤0.01%	323

Other funds holding CLB

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TCTC Holdings's CLB Position: Q1 2026 in Review

TCTC Holdings sold out of Core Laboratories (CLB) in Q1 2026, closing a stake of 600 shares — an estimated $9.62K sold.

TCTC Holdings first reported a position in CLB in Q2 2020 and held it in 23 quarters. The position peaked at $23K in Q2 2021. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.

TCTC Holdings reported no remaining Core Laboratories position as of Q1 2026 after selling out during the quarter.
TCTC Holdings sold 600 Core Laboratories shares in Q1 2026, an estimated $9.62K.
TCTC Holdings first reported a position in Core Laboratories in Q2 2020 and held it in 23 quarters.
TCTC Holdings's Core Laboratories position peaked at $23K in Q2 2021.
190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.

Based on TCTC Holdings's 13F filing for Q1 2026, filed 7 May 2026.